Hengrui Pharmaceuticals: Net profit increased by 235.04% year-on-year in the first half of the year.

Li Sheng Pharmaceuticals released its semi-annual report for 2025, achieving operating income of 732 million yuan in the first half of the year, a year-on-year decrease of 1.76%; the net profit attributable to shareholders of the listed company was 343 million yuan, a year-on-year increase of 235.04%.